HomeNewsWorldCOVID-19 lab origin is one possibility but most coronaviruses are zoonotic: US CDC chief

COVID-19 lab origin is one possibility but most coronaviruses are zoonotic: US CDC chief

Dr. Rochelle Walensky told the US Senate that she has not seen sufficient data to form a conclusion on the origins of the COVID-19 pandemic.

May 21, 2021 / 11:20 IST
Story continues below Advertisement
US CDC (Source: Reuters)
US CDC (Source: Reuters)

US Centers for Disease Control and Prevention (CDC) Director Dr. Rochelle Walensky said on May 18 that laboratory origin of the novel coronavirus (SARS-CoV-2) it "certainly" was "one possibility".

However, Walensky told the US Senate that most coronaviruses generally came “from an animal origin", CNBC reported. She mentioned that she has not seen sufficient data to form a conclusion on the origins of the pandemic.

Story continues below Advertisement

"Certainly the possibilities of, that most coronaviruses that we know of are of origin from, that have infected the population — SARS CoV-1, MERS — generally come from an animal origin," Walensky was quoted as saying by CNBC.

Follow our LIVE blog for updates on the COVID-19 pandemic

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show